Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
lakes, You may have been off on your Genstrip price estimate...
...but you draw no fire for that here. And you're forgiven. LOL!
Assumeing it is a good product, Genstrip is to be sold into a market of 30+ million customers, and growing. Of course, not all who suffer will buy this product, but the repeat sales should be incredible.
And surely the 840K pre-order number is going to grow. The stats posted on the web site are probably already stale data. Hopefully, they will update it this week.
I like your estimates: "$30M in revenues... 5% margin... $1.5M to the bottom line. Makes perfect sense to me. But I would really like to see Instacare book some of this in 2010 so that they will exceed their 2009 yearly earnings. According to the filings I think they only need to earn about $700K to break their previous record. And they may have done that already.
That would result in TWO YEARS of consecutive quarters of increasing revenue. And no end in sight. When will the financial industry wake up to the potential here?
Lakes, glad you're on board here. Good Luck.
VV
Kitju63, I am not familiar with that one. Never heard of it.
In fact, I would only be interested if they are a direct competitor with Instacare. That doesn't appear to be the case. And the PPS is too rich for my tastes.
It looks to be a manufacturer of drugs and not a distributor. I steer clear of that entire Pharma sector because it is just too complicated and almost impossible to pick a winner early on, while shares are cheap. It can take years to develop a new drug. And then they have to go thru a protracted series of field trials before the company can make a dime. Most of them stay alive by selling shares, only to crash and burn before ever getting product to market.
Contrast that with Instacare which has several back-to-back quarters of increasing revenue. They are servicing a market segment (diabetes) that is expanding, so the revenue should continue to increase for the foreseeable future. And they are well-positioned for another market (EHR) that is going to explode. Instacare has actually booked an after-tax profit on occasion. But lately they have used the extra money to extinguish debt. In my opinion, they're doing the right thing for their shareholders, unlike the many dilution machines around.
As far as your pick goes, if you're really interested I suggest that you seek out a forum specific to that stock and ask your questions there. Surely, there will be someone who has done some DD and will share their opinion. Sorry I can't be more helpful.
Good Luck to All Longs.
VV
lakes, Yes, it is definitely showing some real strength today.
It's still early in the session and already the volume is the highest going back to about Aug01. I doubt it will surpass that big spike in volume is late July, which was on a down tick. But you never know.
There is some conversation over on Yahoo about CFO Keith Berman traveling to the Genstrip factory and taking delivery of some samples. So folks who follow the forums are probably aware of that. Real product shipments should start any day now.
And there might be some short covering going on. The "talking heads" on Wallstreet are saying that we're in rally mode right now. Dow now up 109.
Plus, Instacare has been mentioned on a stock trader site today:
http://www.smallcapnetwork.com/Todays-Most-Wanted-IRE-ORCL-and-ISCR/s/article/view/p/mid/3/id/435/
It seems like the stock is finally getting a "tailwind" for a change. Of course, we have all known for some time about the value locked up in this stock. Realistically, if fully valued it should be selling at least twice the price right now, and maybe higher. I am looking for much improved PPS thru the coming weeks.
Unfortunately, I am still in the red here, but I don't think for much longer. I am trying to raise some cash right now.
Good Luck to All Longs.
VV
lakes, Good Find! Thanks for posting that.
That article is interesting because it appears to NOT be directly connected with the recent Health Care Reform legislation and the included financial incentives that are specified as going to the adopters of EHR, such as doctors, clinics, and hospitals.
This article says: "The funding is allotted under The American Recovery and Reinvestment Act." That is part of the, so called, Stimulus Money that was previously allocated. And in this case the money appears to be going directly to states who service Medicaid patients, unlike the Health Care Reform Act money.
So, if I am reading this correctly, this is a completely new government sponsored initiative to push EHR out into the mainstream. As far as I can tell most hospitals and clinics are doing pretty well, whereas most states are in deep financial trouble. So in my opinion, this is a very good idea.
This should accelerate the EHR adoption process. The article says: "...states plan to use the funding to analyze healthcare IT activities." That funds the initial planning phase. And I think we will soon see more grants to more states, primarily those who have larger Medicaid patient populations. I am thinking California and Florida may be on the next list.
Good Luck to All Longs!
VV
ksviking12, I have called and spoken to Keith in the past.
But I have not done so recently.
Thanks for the suggestion.
VV
premonition12, Great! Sounds like you have some very relevant experience.
I am really out of my element when it comes to the drug distribution business. So, perhaps you could occasionally help shed some light on the main business of InstaCare. Please feel free to comment on what you see developing.
Being a retired computer engineer I feel far more comfortable discussing the MDHand and wireless applications in general. I spent the last 10 years of my career designing, programming, and marketing wireless apps. I was also a professional independent consultant for over a decade.
Anyway, that's all behind me now. Since then I have become more proficient in reading stock charts (technical analysis) and analyzing SEC filings (fundamental analysis). With my tech background it is in my nature to be very analytical. And over the decades I have developed an "eye for quality", so to speak, which now serves me well.
I am very confident in the quality of this investment. And I can readily imagine Instacare achieving "50 million in sales", but perhaps maybe not overnight. But I'm sure it's going to be an awesome pattern of growth.
Good Luck to All Longs.
VV
All I can say is I wish I had more money to invest here.
And I think you are correct in that the future expectations are not currently priced in.
We don't yet know how the Genstrip product will be received by the market. However, there are already substantial pre-orders, and Instacare has a 5-year "exclusive" on the distribution. So the early signs look very promising.
We do know that over 30 million people in the USA are afflicted with diabetes. For a while now this has been considered to be an epidemic. So I sincerely hope that the Genstrip will help those who are suffering. And if it does then we are probably looking at several millions of dollars in sales each and every quarter for the next 5 years.
This is just the beginning. I think this is going to get a lot better once Genstrip starts shipping. Any day now and... BANG! We're off to the races again.
Good Luck to All Longs.
VV
CRAY files SEC form 8-K on 09/17/2010
http://knobias.10kwizard.com/contents.php?ipage=7156378&rid=12&back=1
VV
Another nice move. Closed UP 30% today.
Third UP day in a row, PPS has more than doubled this week.
We're obviously on a roll here.
Good Luck to All Longs.
VV
News: Shrink Nanotechnologies' Innovative Stem Cell Culturing Technology "StemDisc" Nears Commercialization
Last update: 9/17/2010 4:00:00 PM
CARLSBAD, Calif., Sep 17, 2010 (BUSINESS WIRE) -- Shrink Nanotechnologies, Inc. ("Shrink") (INKN), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products.
Within the last week, Shrink has received the final mold for the initial StemDisc product line. The balance of the design parameters have been completed, and the Company will begin building and testing the prototype commercial iterations of the StemDisc 450, which has been designed to allow biologists and researchers to culture HESCs (human embryonic stem cells) as well as IPSCs (induced pluripotent stem cells) with amazing simplicity, in an advantageous form factor and at a much lower cost. Shrink expects to begin to offer the product sometime in the 4th quarter of this year
Commenting on this news, Shrink CEO and founder Mark L. Baum stated, "When we began the development of this product, we saw an opening in a sizable and growing market, provided we were able to offer a product that was superior in performance, cost and ease of use relative to the current available systems for growing EBs (embryoid bodies) and IPSCs. Now that we are nearing the final phase of the design and commercial prototyping stage, we believe we will have met and exceeded what we thought we would be able to do. We intend to debut images of the final designs as well as the initial prototype product this month."
About Shrink Nanotechnologies, Inc.
Shrink Nanotechnologies, Inc. () is a one-of-a-kind FIGA(TM) organization, which focuses on leveraging contributions from experts in Finance, Industry, Government and Academia. Operating as a high-technology development-stage company, Shrink owns and develops proprietary and patent-pending nano-sized technologies, components and product systems. The Company's unique NanoShrink(TM) material is a pre-stressed polymer which is used in a patent pending manufacturing platform with numerous applications in the solar energy, human and animal diagnostics, and biotechnology research and development tools industries.
Looks like the 50MA will soon cross above the 200MA ...
...probably on Monday. That is called a Golden Cross and it is a bullish sign.
http://stockcharts.com/h-sc/ui?s=IWEB&p=D&yr=0&mn=3&dy=0&id=p32267327418
VV
VF8, The numbers posted are the starting point of a new sales trend.
And if this is what has been achieved right at the start then it will probably grow quite rapidly going forward. IMO this is going to be BIG.
Of course, these numbers represent orders and NOT sales. But all of this will eventually translate into NEW revenue for the company. And from these early numbers I think we can reasonably assume that InstaCare will probably earn millions of dollars off of this ONE product.
Personally, I seldom question the "purpose" of companies doing things like this. The short answer is that shareholders and customers want to know about it. It helps fill in the picture of what is happening and builds market demand. And if they didn't do it, most likely, someone would probably call and complain about it.
Good Luck to All Longs.
VV
Nice move, closed UP 46% today.
For about two minutes this morning I was actually in the Green again.
Let's see what tomorrow brings.
VV
KnightQB7, LOL! YOU are anonymous.
PR says "...expects to begin commercial sales this year."
That's Great! That means revenue and potentially a profit.
It also means less possibility of share dilution.
All just my opinion...
VV
News: Shrink Nanotechnologies Provides Update on Projects and Commercialization Efforts
Wednesday September 15, 2010, 4:00 pm EDT
CARLSBAD, Calif.--(BUSINESS WIRE)--Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN - News), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, issued the below update to the market regarding its commercialization efforts as well as the implementation of several new commercial initiatives.
Shrink CEO and founder Mark L. Baum stated, “Over the summer, the Company has focused on turning the ideas and innovations of our scientific founder and development team into commercial products. This work has been focused on NanoShrink and StemDisc, as well as several new and important initiatives that the Company will discuss over the coming months. The 'take-away' news from our standpoint is that we have made significant technological and product development progress in what has been an extremely challenging economic time. We believe that the progress we have made and the innovation we have funded during a time when many small companies shuttered their doors will bode well for us as we emerge from this challenging time in our economic history; and we look forward to unveiling what we’ve been working on.”
Shrink’s Core NanoShrink Family of Products
NanoShrink is a sheeted pre-stressed polymer material that “shrinks” by up to 95% when heated. When printed on, or cut or etched into, users are able to create patterns at the “macro-scale” and then “shrink” their designs to the micro or even nano scale after heat and other treatments are applied. The resulting patterns are used as molds or even as complete systems in a myriad of commercial and even recreational uses. The NanoShrink system is extremely flexible in terms of use, low in cost and has the capability of dramatically reducing the time-to-market for prototype products in a number of large markets.
Shrink has designed its acclaimed StemDisc cell culturing devices with NanoShrink, as well as low cost microfluidic systems and numerous other artisanal biotechnology and solar energy projects. Of late, we have begun experimenting with NanoShrink by using it for printed electronics applications and as a substrate for low cost high sensitivity immunoassays. We have also begun the development of low cost, multi-use NanoShrink science kits for the K to 3rd grade, 4th through 8th grade, high school and college level markets.
This year the Company decided to develop a commercial version of the NanoShrink material and to offer it for sale as a “platform” so that users could develop their own applications – similar to the model employed by Apple for its iPad and iPhone systems. Shrink envisions a community of users creating applications (or “apps”) and building a marketplace where developers’ NanoShrink-based apps can be purchased.
Shrink’s development has been recognized nationally and internationally in leading academic journals for the potential for NanoShrink.
The Company is close to releasing the initial version of the NanoShrink material to a select group of professors and researchers, and is in the final phases of evaluating commercial prototypes which are being delivered to Shrink by key suppliers. The Company expects to launch this product sometime during 2010 and make regular announcements regarding enhancements and innovations made to the NanoShrink material which will demonstrate how NanoShrink can be used for additional potential applications.
NanoShrink Tools
In order to optimize NanoShrink for certain biotech applications, our team has designed a suite of design tools for NanoShrink, including a solid-state oven, a press and other implements.
As an example, NanoShrink has different performance features which are dependent on factors during the shrinking process, including, temperature, pressure and time exposure. The suite of NanoShrink Tools will address optimizing the performance of NanoShrink material, allowing users to get more from NanoShrink.
The Company is currently evaluating commercial prototypes and is negotiating with suppliers to produce the suite of NanoShrink Tools and expects to begin commercial sales this year.
StemDisc Cell Culturing Platform
StemDisc is a unique cell culturing platform used by researchers to grow IPSCs (induced pluripotent stem cells) and (HESCs) human embryonic stem cells. In the future, the Company intends to develop the StemDisc platform to grow larger aggregated cell structures, including tissues. The market for cell culturing tools, specifically related to stem cell development tools, is growing rapidly as leading researchers in the United States and all over the world are reaching a consensus that working stem cells for regenerative therapies and to perform basic research on will be a key to finding treatments and cures for many of humankind's most perplexing conditions and diseases.
The Company has made significant progress on StemDisc – in terms of the design of the overall system, the material it is made of, and the ability of the Company to offer additional related products to enhance the use of the system. What was an effort to build one product for one specific application in a growing market, has become the development of an entirely new cell culturing platform for the Company to use its NanoShrink material to design microstructures and microwells for numerous product applications. The Company is completing production negotiations with various suppliers and believes that the first of the StemDisc family of products will be offered for sale sometime during the last quarter of this year. Additional product and related technology announcements for this suite of StemDisc products will be forthcoming.
New Developments
The Company has been working on at least four (4) significant new lines of business, some with major industrial companies and leading universities and others which have been developed wholly by Shrink. Over the coming months, the Company intends to discuss these efforts in more detail as items become newsworthy.
About Shrink Nanotechnologies, Inc.
Shrink Nanotechnologies, Inc. (www.shrinknano.com) is a one-of-a-kind FIGA™ organization, which focuses on leveraging contributions from experts in Finance, Industry, Government and Academia. Operating as a high-technology development-stage company, Shrink owns and develops proprietary and patent-pending nano-sized technologies, components and product systems. The Company's unique NanoShrink™ material is a pre-stressed polymer which is used in a patent pending manufacturing platform with numerous applications in the energy production, human and animal diagnostics, and biotechnology research and development tools industries.
http://finance.yahoo.com/news/Shrink-Nanotechnologies-bw-1192106489.html?x=0&.v=1
VV
Cast Iron, I believe strongly that it will take off.
And I don't think it will be too much longer; a couple of months, maybe.
Now that the economic "double dip" appears to be off the table the overall market sentiment has switched to accommodate a more speculative direction. In short, penny stocks are coming back into favor. Folks are again buying stocks like this. And I think this one is way under-valued at the current level, so it wilkl be a good deal for somebody.
Now that Metapower has an in-house accounting person we should be getting a more regular stream of financial information. I think the shortage of financial info is what has really held this stock down, more than anything else.
And we have the new product launch which should be happening soon. I am sure that they will use that to draw more attention to the company. It might even bring a few more customers on board.
In the end, virtually all penny stocks are "news driven". And it looks like there is an increasing list of good things that Metapower can PR.
And finally, there's the Monty Python factor: "Expect the unexpected".
It would NOT surprise me one bit if some bigger richer company attempts a merger-acquisition here. For example, I know that IBM has a growing portfolio of software products aimed squarely at the oil industry. IBM has billions of dollars available for M&A and they just recently bought another company. Metapower's product is not really that far afield from what IBM has purchased in the past. And they are not the only potential buyer; there are many.
Of course, there's just no way of knowing when this situation may get more exciting. So further patience is the key to being rewarded here. But personally, I have no doubt that it will happen.
Good Luck to All Longs.
VV
gman3, I suppose it gets updated as the orders are received.
Might be fun to watch as the product gets rolled out.
Good Luck.
VV
Genstrip pre-orders at PharmaTech are picking up quickly.
In fact, it's beginning to look like a tsunami forming.
http://www.pharmatechdirect.com/genstrip.html
Good Luck to All Longs.
VV
getmoreshares, I sincerely hope it exceeds expectations, too.
I didn't mean in 6mos. I meant to post 6 weeks!
The Christmas season always brings an Internet Online Bazaar of shopping. It could be a lot bigger this year, as an emotional relief from the recession ending. And Warp9 is solidly into eCommerce as a vendor of tools for sellers of consummer products. So, I would think that right about now they would be signing up some new customers, etc.
And my prediction of .01 is just a tick above the 52-week high of Oct13. So I was trying to be conservative in my estimate.
A one penny share price is less than a triple from here. It could easily do that and more. In fact, just this week I saw one stock exceed 400% gain in the space of 2 hours, all based on a single order. The market has turned in favor of penny stocks again.
So I say Let'r Rip!
VV
GBVS stock PPS now UP 87% on the day...
...after a prolonged quiet period.
Perhaps there's some news coming?
VV
Personally, I'm looking for a penny or higher within 6 months.
I have done my DD here and this one is way undervalued.
All just my opinion...
VV
Upside Resistance now at .0037
So we have a little more room to move.
VV
GBS products to be exhibited at upcoming Chicago trade show
"Innovations that work for you: improved sustainability, reduced cost and increased revenue
August 02, 2010
Graphic Packaging International, Inc. (GPI), a subsidiary of Graphic Packaging Holding Company (NYSE: GPK), today announced that it will be an exhibitor at the Pack Expo 2010 tradeshow, sponsored by PMMI (Packaging Machinery Manufacturers Institute), and held at McCormick Place in Chicago, Illinois, October 31 through November 3, 2010.
"Innovations that work for you: improved sustainability, reduced cost and increased revenue" is the 2010 theme for GPI's expansive exhibit at Pack Expo.
And that's exactly what visitors to booth S-1533 will find on display as the company showcases some of the most innovative packaging and machinery solutions available in the world today to effectively address challenges such as barrier control, interactive packaging, microwave packaging, distinctive label application, package strength, and automating packaging lines.
"Pack Expo has a rich history of bringing together industry leaders from around the globe to share the best and brightest packaging ideas - and in this tradition, we're bringing together proven new solutions that can help consumer brand manufacturers build both sales and customer loyalty," said John Best, GPI's Vice President, Business Development.
Some examples of what GPI plans to showcase at Pack Expo 2010:
* Global Beverage Solution -- Graphic Packaging has been providing integrated multi-pack solutions for leading beverage brands around the world for more than 50 years. The company delivers proven, powerful performance at each step of a beverage customer's packaging value chain."
Complete article:
http://www.globalprintmonitor.com/en/industry-news/packaging/29105-innovations-that-work-for-you-improved-sustainability-reduced-cost-and-increased-revenue#axzz0zWxOzIud
VV
If only the British Petroleum (BP) execs had read this earlier...
From the Metapower LLC BLOGS:
"Is Plant Management A Noble Endeavor?"
September 10, 2010
http://www.metapower.com/blog/2010/09/13/is-plant-management-a-noble-endeavor/
It provides good reason to believe that Metapower's sales will be expanding.
VV
i-Glide, "...built upon ... European-styled leisure concept."
I believe that phrase also means clothing is optional.
There is always plenty of that at Sturgis.
VV
He is a site which I find useful for answering that type of question:
http://www.secfile.net/SEC_calendar.htm
VV
BarChart's TA opinion of MTPR is much improved:
Short Term Indicators Average: 80% Buy
Medium Term Indicators Average: 25% Buy
Long Term Indicators Average: 33% Buy
Overall Average: 40% Buy
http://www.barchart.com/opinions/stocks/MTPR
VV
From the fundamental standpoint it looks like InstaCare ...
... is right on track to achieve its 3rd Year in a Row of Increasing Gross Profits.
Prior Gross Profit:
2009 - $1,579,671.
2008 - $1,478,513.
----------
2010 1st Qtr - $388,017. from 10Q of 5/17/10
2010 2nd Qtr - $537,423. from 10Q of 8/18/10
So they only need about $655K to top their previous record, and they have TWO quarters to earn it. That's about $328K per quarter. They probably already have it.
Since they've had some increasing positive momentum over the last few years I am guessing that they will do much better this year.
The previous 10Q says:
"The distribution of medical products and medical diagnostics in aggregate account for the overwhelming percentage of our revenues. Our experiences point to a business that displays certain seasonal trends. In each of the last three operating years our order intake was concentrated in the first five months of the calendar year and to an identifiable degree in the months of October and November. One explanation is that these months correspond with the beginning of a prescription drug plan years, October and November being the first two months of the federal Medicare formularies, ... This tends to influence “stocking up” buying/ordering behavior on the part of the patients who routinely order multi-month supplies. The company believes that the seasonal trends in calendar year 2010 will be further influenced by the launch of its new at-home diagnostic testing product, Genstrip, as sales of this new product will begin in October 2010."
And of course the GenStrip and the future EHR product haven't even kicked in yet. But stay tuned or check back in a week! We may even receive a Patent soon. I am sure this is all going to be really big in the very near future, but it hasn't quite arrived yet. Any moment now...
Meanwhile, Instacare will increase its record to 3 Consecutive Years of Increasing Gross Profits. A record for a penny stock? I would think that at some point this stock will be recognized by the wider market and be rapidly bid up by professionals. The Institutions will eventually take over the float.
This stock might launch hard at any moment... But then again, maybe not for a little while longer. But, I'm just sayin' ...
Good Luck.
VV
Kitju63, I totally agree on "Let him go... for now, let's hope ISCR makes us all a little richer in the NEAR future!"
That's, pretty much, IT in a nut shell. Well stated!
If folks would just do a little Due Dilligence, watch carefully what the company is doing, watch what the industry is doing. Then you should be able to see how these trends are coming together in a rewarding intersection. It is generally referred to as "positioning", and Instacare seems to have it well in place.
So, these voices that are whining and complaining, sometimes screaming, from the sidelines are just so much noise and a deliberate distraction. They're just trying to draw attention to themselves, in order to deflect useful discussion so that the vision of this investment is never fully explored. Don't fall for their ploy; don't take the bait. Make up your own mind.
Let's all just Take the High Road here, and stay focused only on Instacare, the company and the stock. Let's discuss it.
Good Luck to All Longs...
VV
premonition12, "...information is very unreliable..."
Has it ever occurred to you that everyone on these forums is posting behind an alias? I certainly have, and I take that into account whenever reading these forums.
So, from my perspective, the idea that actual "information" (as in facts) is being disseminated here (or else where) is just laughable. What you perceive as information is actually just someone's opinion, probably based on their agenda, and nothing more. Anyone can predict anything at anytime, but that doesn't make it true.
And NO ONE should ever base any investment decision solely on posts on a public forum. That is just asking for trouble. But I do realize that far too many humans are just way too lazy for their own good, and that's exactly what they do. Well, that's THEIR problem, if they want to believe this stuff.
I must have posted this a thousand time on the forums over the last decade:
Everyone should do their own Due Diligence.
As I am sure you already know, Instacare publishes routine financial filings with the SEC. Those are signed under penalty of perjury. As far as I am concerned those filings can be taken at full face value. But of course, they have to actually be read in order to digest the real "information" contained therein. And the periodic press releases build upon the foundation set down in those filings.
Beyond that, anything published on this forum, or ANY other forum, should be viewed as the "opinion" of the writer and nothing else. It should be verified before ever acted upon.
Now, when "Genstrip presales" actually begin I am sure that InstaCare will notify us. It is a "material event" and it is very much in their best interest to tell the world. IMO the company is the ONLY valid source for this information.
So PLEASE, just stick with the facts and don't bother commenting on rumors posted on some other forum. And especially, don't comment on the credentials or veracity of other individuals anywhere as in "unreliable source", because that is clearly Off Topic and may also be construed as a Personal Attack within the site Terms of Usage.
All just my opinion...
VV
premonition12, With regard to Instacare's EHR technology...
...the MDS Hand product, software, etc., my understanding is that, up to now, they have only been the primary technology developer. And additional development will be required to get it to market. I don't see any plan emerging to sell this technology DIRECTLY to hospitals, clinics, doctors, etc. As a matter of fact I would be astonished if they even tried that. They are actually engaged in trying to find one or more partners, so as to license it to 3rd parties who will take it to market.
This is all well documented. So you are bringing something completely new and fully outside of the scope of Instacares stated plans, as they have described them.
The 10Q of 8/18/2010 states specifically:
"We have received seven inquiries from companies interested in partnering with the company for the implementation of its cell phone centric technologies MD@Hand and MD@Work. The interested companies range from clinical testing laboratories, service organizations owned or aligned with medical health insurers, a medical content provider and legacy healthcare systems companies. All seven companies are much larger than instaCare. We have chosen one of these companies as a proposed partner and are in wide ranging discussions. We plan at least one additional proposed partnership."
Given the path that Instacare has described and assumed to be following, I see NO possible "competitive disadvantage" for not having these things you have pointed out as missing. Clearly, they don't need any of that. The actual product rollout, when it happens, will be through one or more of their chosen distributors, "companies ... much larger than instaCare." I believe that is absolutely the best way to proceed. And there will be no possibility of a "competitive disadvantage" because they won't be involved in the marketing aspect. It is strictly a licensing deal.
They have yet to identify just who the distributor will be. But I am sure it will be a company of good industry stature and experience, and better equipped to enter this new EHR industry; a company that ALREADY has the means to be successful right from the start. Undoubtedly that company will have to deal with the issues of certification, sales, etc. that you mention. But InstaCare will NOT. That is the whole idea of having a partner; to establish a division of labor and responsibility.
You and I (and others) may differ on this opinion, but I do not see the EHR business as an immediate concern since the market has not matured and there is substantial work left to be done on the regulation and certification front. It will probably get going next spring.
For InstaCare the real excitement is surrounding the Genstrip product rollout which is happening NOW. Realistically, this will probably bring at least $10 million in revenue BEFORE the EHR product rollout.
Good Luck.
VV
connie824, There is a big difference between EHR and EMR.
It is obvious that this distinction is not well understood in the investment community and is the cause of much confusion.
EHR = Electronic Health Records
EMR = Electronic Medical Records.
They are no where near the same thing.
Most doctors, clinics, hospitals, etc. already store their records electronically. This is what is generally referred to as EMR (Electronic Medical Records). But there is no standard way of doing this yet. So currently, there is just no way they are going to provide all of this to the patient, because the next doctor wouldn't be able to deal with it.
The EHR (Electronic Health Records) is the "subset" that will be provided and can be carried around by the patient.
The EHR will include things like the prescriptions you're taking, reference to whatever conditions you might suffer from, etc. Or the Rehab regimen you're supposed to be following. And if you have a pace maker or a replacement hip, etc, there will be info about that. They certainly won't want to run you thru a Mag-Rez machine if you have metal inside you. And if you're unconscious then you can't tell them about it.
There probably won't be any referrence to the doctor who actually installed the pace maker or metal hip. Or when and why it happened. And I doubt there will be anything about the current pre-diagnosis study that you are now going through. But there should be more than enough data available so that you can be effectively and quickly treated, should you be far away from you primary care provider. But there won't be enough to reconstitute your medical history. For that, they would have to contact your primary care giver.
The larger body of data called EMR would include things like X-Ray scans, EKG readouts, in-depth clinical information concerning all sorts of things in great detail. Too many to list here. And it is very historical in nature and far more then just a current snapshot. It would include info that can only be interpreted by your primary care giver, and not some ER doctor. This type of info just isn't likely to be provided under any circumstances.
Right now, the laws and regulations surrounding Patient Privacy are even more strenuous that those that control banking and credit information, Social Security, etc. This is why the security of data is the main issue that is being dealt with right now. There are several proposed methods under consideration. In making the data more secure they will have to make it more difficult to access by your temporary doctor, should you need treatment. So the key is going to be the kind of standard infrastructure that evolves from this.
All of this constitutes a very involved technology problem to be solved, with a lot of parts that haven't been nailed down yet. It is very interesting to folks with a technical background, but somewhat opaque to the layman. And whatever the industry chooses to do it will probably evolve continuously over time.
Incidentally, I've never seen my doctor write anything down on paper. He uses a tablet computer with a stylus. Then when he is thru dealing with me he syncs it up with his work station in the his office, and that automatically updates my data on the bigger server hidden from view. Last year, when I had my prior health records ordered from Kaiser Permanente I was shocked to see that they arrived as 80+ individual Fax pages. There must be a better way to do this. And I'm thinking that this is the bigger part of the problem; the transmission of records directly between doctors where data security is not so much a concern.
Good Luck.
VV
MrLucky, Far be it for me to try to tell YOU how to invest YOUR money.
But if you read any good book on investing you will quickly learn that the #1 goal of the investor SHOULD ALWAYS BE:
Capital Preservation.
If you concentrate your money you are compounding the risk. And if you lose all of your money on one play, then GAME OVER. Obviously, you have to stay in the game in order to win.
Your method might work fine with Blue Chips, especially those that pay dividends. Blue Chips hardly ever go to zero.
But doing so on a penny stock is like playing Russian Roulette. If you happen to win one time it is just going to set you up to lose the next time. The so called "technique" you are using is called "trying to buy a win". It just doesn't work for long.
I do understand that if you're just starting out and have very little capital then you almost have to do it that way. But in general terms it just isn't a good idea. I suppose the point is that you need to understand the concept of "strategy", adopt one, and evolve it over time toward taking on LESS risk as you become more proficient.
I am really NOT in the business of giving financial advice. I would really like to see you win on your investments. I would like to see everyone win. But trying to learn investing in penny stocks is one of the toughest environments there is. So be the student and always be very cautious.
Good Luck.
CH, sorry for this OT post, but I have almost exhausted my daily free-15 so I'll be leaving now.
VV
bronen, You would probably get an execution at a lower price.
The MMs are required by regulation to give the "best price available" in the market at the moment your order appears.
If they don't do that then you would have good cause to complain to the regulators.
But here's an idea. If you really want to pay that much why don't you contact MonkeyRock directly? I am sure they will be willing to help you out.
Good Luck.
VV
MrLucky, Again, the answer is in the Macro Economic picture.
It is not so much about COPI as it is about the economy. The speculative money has long since fled the market and moved into Bonds, seeking safety.
If folks are worried about putting food on the table and gas in their tanks, the last thing they're going to do is invest money in the penny stock market, which everyone knows is very risky.
But there has been a kind of "sea change" lately. The economy has improved slightly and folks are feeling a little bolder; willing to take on a little risk to achieve big gains later on. This company is well positioned to take advantage of the early revival of the economy. To me, this is the main point.
But even though hiring has started again, we may actually see an increase in unemployment in the near term because many job seekers have flat out given up. So you always need to read the signs and leading indicators correctly.
That's why I think that watching the high-level top-down Macro view is far more useful in understanding COPI, rather than looking directly at the company and its fundamentals, etc. It is sort of like "leading the target".
I'm here and long shares, so obviously I think COPI has a reasonable shot at improving over the coming months. But I'm not in very deep so I can afford to be very patient.
Good Luck.
VV
gussy1, "...if something finally popped..."
I realize that it can be very frustrating when a situation doesn't develop as fast as one wants it to.
So, from my viewpoint, the way to deal with that frustration is to simply limit your "emotional exposure" but putting less money into any one position. Find you personal "comfort zone" and stay within it.
Spread the money around a little, say over 10 stocks. That way you can afford to be patient with each one. And there always seems to be one or two that are becoming active. So you won't be so easily frustrated. I have only a few hundred dollars at work here, and I'm as happy as a "clam in the ocean". LOL!
The worst thing you can do is to concentrate all of your money into one or two positions. That drastically increases the possibility of having "dead money" for months on end. Been there-done that!
Call it strategy or whatever, but always listen to your gut. Be analytical, and if your strategy isn't working for you then respond and find another way. Understand where your "comfort zone" is.
And, as you've pointed out, Metapower is a slow mover. But when it does move it does so in a Really Big Way. So being patient is key to being rewarded here. At the risk of sounding like a pumper, I fully expect to get a 300% ROI on my investment.
Good Luck.
VV
lakes, Well, Thank You!
At least there's one of you! LOL!
When I was young I was a warrior. But now that I am older I have morphed into more of a diplomat. I believe in reaching out to others in order to find common ground, building agreement, and concentrating resources, etc.
We can do far better with InstaCare if we work as a group toward a common goal. Rather than trying to fight individual battles that can't be won anyway.
Good Luck.
VV
MrLucky, Lately I've been seeing a lot of penny stocks turning up for no apparent reason.
I think that COPI responds more to the Macro Economic picture than others do.
Lately, the market has been up because the "double dip" is now clearly "off the table", so to speak. A lot of companies are making good sales and profits, so the GDP is going up a little faster as the economy is healed.
Furthermore, as business improves hiring of employees has picked up a little. More than any other group these factors directly benefit the Consumer. Both of the operational divisions of COPI, telemarketing and hiring tools, are directly targeting that group of Consumers, as employees and spenders.
So COPI, the stock, is probably at or near the lowest price we shall see it for years to come. As the consumer gets healed by getting hired, they are also going to start spending their earnings again. Some of that will happen thru telemarketing, which will expand as a biz segment.
It seems obvious to me that the telemarketing biz will soon follow the resurgence in hiring. And both will benefit COPI. Let's just hope that the economy continues to hold together for a while longer.
But unfortunately, according to the Mayans and Nostradamus, the world is supposed to end on Dec21, 2012. So I really don't know what the longer-term future will bring for COPI.
All just my opinion...
VV